Mineral Oil USP (Pharmacopeial Light + Heavy White Mineral Oil Emollient Lubricant Laxative) Storage

Mineral Oil USP (Pharmacopeial-Grade Highly Refined White Mineral Oil; Light + Heavy Grades) Storage — Compendial Mineral Oil Tank Selection at Pharmaceutical Manufacturing, Compounding Pharmacy, Topical-Cream + Suppository + Ophthalmic Operations

Mineral Oil USP (also called white mineral oil USP, heavy mineral oil USP, light mineral oil USP, liquid paraffin USP, liquid petrolatum, paraffinum liquidum; CAS 8042-47-5; mixture of saturated aliphatic + cyclic hydrocarbons C15-C40) is a clear, colorless, odorless, tasteless, oily liquid produced by deep refining + acid treatment + decolorization + hydrogenation of petroleum distillate fractions to remove all aromatic + olefinic + sulfur + nitrogen species, leaving only saturated paraffinic + naphthenic hydrocarbons. The USP-43-NF-38 monograph distinguishes Light Mineral Oil USP (kinematic viscosity under 33.5 cSt at 40°C, often 8-20 cSt) from Heavy Mineral Oil USP (kinematic viscosity 38.1 cSt or higher at 40°C, often 60-80 cSt). Both grades meet pharmacopeial requirements for purity: specific gravity 0.83-0.86 (light) or 0.86-0.89 (heavy); UV absorbance limits at 260-350 nm per USP <201> demonstrating absence of polynuclear aromatics; readily carbonizable substances, solid paraffins, neutrality, residue on ignition, heavy metals, and limit of organic solvents per USP <467> all within compendial limits. The harmonized Ph. Eur. 11.0 Liquid Paraffin monograph and JP 18 Liquid Paraffin monograph carry parallel specifications.

Pharmaceutical USP mineral oil functions as topical emollient + ophthalmic lubricant + oral laxative + capsule lubricant + suppository base + tablet release agent + ointment vehicle across a wide pharmaceutical formulation set. Topical use (light mineral oil) in baby oils, dermatologic emollient creams + lotions + ointments, after-shaves, sunscreens, lip balms; ophthalmic use (light mineral oil) in artificial-tear and lubricant eye-drop formulations + ophthalmic ointment bases; oral use (heavy mineral oil) as Fleet Phospho-Soda Mineral Oil oral laxative (Kondremul, Fleet Mineral Oil) at 15-45 mL adult dose for relief of constipation; suppository + ointment formulations using mineral oil + petrolatum + lanolin + beeswax base. Physical properties: specific gravity 0.83-0.91 depending on grade; density slightly under water; viscosity 8-20 cSt (light) or 60-100 cSt (heavy) at 40°C; flash point 168-220°C closed cup; autoignition above 260°C; pour point -10 to -20°C; immiscible with water (forms two-phase emulsion); fully soluble in benzene, chloroform, ether, petroleum ether; tasteless + odorless when fresh.

The eight sections below cite USP-NF 43, Ph. Eur. 11.0, JP 18, FDA 21 CFR Parts 210 + 211 + 600-680, USP <201> UV Absorbance Test for Mineral Oil, USP <467> Residual Solvents, USP <1116> Microbial Bioburden, ASME BPE-2022, FDA 21 CFR 172.878 White Mineral Oil for direct food contact, FDA 21 CFR 178.3620 White Mineral Oil for indirect food contact + petroleum jelly applications, ICH Q7 + Q9 + Q10, and operating practice at Sonneborn (Sonneborn LLC), Calumet Specialty Products, Petro-Canada Lubricants (HT Hyprx Pharma series), Penreco (Calumet), Renkert Oil, Eastman, Witco-Sonneborn, and pharmaceutical manufacturing operations at Pfizer, Johnson & Johnson Consumer Health, Sanofi, GSK Consumer Healthcare, Beiersdorf, Galderma, Bausch + Lomb, and similar pharma + ophthalmic + dermatologic + OTC operations.

1. Material Compatibility Matrix

Pharmaceutical USP mineral oil is a deeply refined paraffinic + naphthenic hydrocarbon stream with no chemical reactivity in normal handling. Material compatibility considerations differ meaningfully from aqueous polyol USP (glycerin, propylene glycol) because mineral oil is an inert hydrocarbon: HDPE + polypropylene + LDPE swell substantially in mineral oil at extended contact + elevated temperature; carbon-steel + stainless steel + glass-lined steel + 316L stainless are unaffected. The matrix below covers both bulk-receipt + bulk-storage applications and product-contact / formulation service.

The dominant industrial pattern at pharmaceutical mineral-oil-using manufacturing is steel + stainless from the receiving manifold onward: stainless or HDPE-lined tank-truck receipt, HDPE intermediate-bulk staging at the raw-material warehouse with awareness of the long-term swelling concern, then prompt transfer to 316L electropolished sanitary stainless formulation tanks for product-contact service. Compounding pharmacies and small-batch operations often handle USP mineral oil entirely in HDPE drum + tote with regular working-stock turnover (under 6 months) limiting cumulative HDPE swell exposure. OneSource Plastics' 5-brand HDPE network covers the bulk-receipt + raw-material-warehouse + compounding-pharmacy + ambient-temperature non-product-contact short-term ingredient-storage envelope; ASME BPE 316L sanitary stainless tanks for product-contact ointment + cream + lotion + ophthalmic + suppository formulation are outside the HDPE scope.

2. Real-World Industrial Use Cases

Topical Dermatologic Emollient Manufacturing. Light USP mineral oil is the dominant emollient base in baby-care + dermatologic moisturizer + cream + lotion formulations. Iconic products include Johnson's Baby Oil (USP mineral oil 98%+ with fragrance), Aveeno Baby Oil, Cetaphil Restoraderm, Aquaphor Healing Ointment (petrolatum + mineral oil + lanolin alcohols + ceresin + glycerin + bisabolol vehicle), Eucerin Original Healing Cream, and a wide range of OTC + dermatologist-recommended skincare products. Inclusion 5-95% w/w depending on product type. Manufacturing at Johnson & Johnson Consumer Health, Beiersdorf (Eucerin, Aquaphor, Nivea), Galderma (Cetaphil), Bausch Health (CeraVe). Heavy mineral oil at 60-80 cSt provides occlusive barrier function in protective ointments + diaper-rash creams.

Ophthalmic Artificial-Tear and Lubricant Eye Drops. Light USP mineral oil is included in lipid-restoring artificial-tear + lubricant eye-drop formulations (Soothe XP, Refresh Optive Mega-3, Systane Balance) at 1.0-4.5% as oil-phase in two-phase ophthalmic emulsion stabilized with surfactants (polysorbate-80, polyoxyl-40-stearate, lecithin-derived emulsifiers) and gelling agents (carboxymethylcellulose, hyaluronic acid, polyvinyl alcohol). The lipid-phase mineral oil restores the tear-film lipid layer disrupted in evaporative dry-eye disease. Sterile, low-bioburden, low-endotoxin, low-particulate USP mineral oil is required per USP <71> sterility, USP <85> bacterial endotoxins, USP <788> particulate matter, and USP <788> subvisible particles.

Oral Mineral Oil Laxative. Heavy USP mineral oil (60-80 cSt grade) is the active ingredient in OTC oral laxative preparations: Fleet Mineral Oil 100%, Kondremul Plain (Heritage Pharmaceuticals), Fletcher's Castoria competitor preparations. Adult dose 15-45 mL at bedtime; mechanism of action lubricant + stool-softening through poorly-absorbed lipid coating of stool through the colon. The pharmacopeial-grade purity + low UV-absorbance (USP <201>) is critical to limit polynuclear-aromatic + carcinogen exposure from the oral mineral-oil dose. Manufacturing at C. B. Fleet Pharmaceuticals, Heritage Pharmaceuticals, Perrigo OTC.

Capsule + Tablet Release Lubricant. Light USP mineral oil + heavy USP mineral oil function as tablet-press release agent + softgel-capsule shell-mold lubricant in solid dosage manufacturing at industrial scale. Inclusion is ppm-level (residue limits per ICH Q3D + Q3C) and process-incidental rather than formulation-included.

Suppository Base Manufacturing. Heavy USP mineral oil is included in mineral-oil + petrolatum + cocoa-butter + PEG suppository base formulations for hormonal + analgesic + antiemetic delivery. Inclusion 5-30% w/w in the suppository base depending on hardness + melting-point + drug-release-profile design. Manufacturing at Ferring Pharmaceuticals, Catalent, Padagis, Perrigo.

Liquid Paraffin Pharmaceutical Petroleum Specialty. Sonneborn LLC, Calumet Specialty Products, Petro-Canada Lubricants HT Hyprx Pharma series, Penreco (Calumet), Renkert Oil, and a small number of dedicated pharmaceutical petroleum specialty refiners produce USP-grade light + heavy mineral oils + petrolatum + microcrystalline waxes from ultra-deep-refined petroleum distillates. Pharmaceutical-grade is a specialty product distinct from technical-grade industrial process-oils (Group I, II, III lubricant base oils).

Compounding Pharmacy Working Stocks. 503A + 503B compounding operations stock USP mineral oil (both light + heavy) in 1-pint to 55-gallon to 275-gallon IBC tote sizes for use in patient-specific topical, suppository, and oral compounded preparations under USP <795> non-sterile + USP <797> sterile + USP <800> hazardous-drug compounding standards.

3. Regulatory Hazard Communication

OSHA HazCom GHS Classification. USP pharmaceutical mineral oil (light + heavy grades) is generally not classified as a GHS hazardous substance at the pharmacopeial-purity refining level. Flash point 168-220°C closed cup places it as Class IIIB combustible liquid per NFPA 30 (above 93°C); not flammable in normal handling. No GHS health hazard classifications at oral, dermal, or inhalation routes when meeting USP <201> UV-absorbance + readily carbonizable substances + heavy-metals limits (lower-grade petroleum distillate fractions outside USP specification can carry IARC Group 1 carcinogen classification due to polynuclear aromatic content; USP-grade specifically excludes this hazard via deep-refining + UV-absorbance specification). Environmental: not readily biodegradable + low aquatic toxicity; mineral-oil spills require recovery + soil decontamination similar to petroleum-product spill response. H-statements: typically none required for USP grade. P-statements: P210 Keep away from open flames + hot surfaces (heated bulk storage above flash point).

FDA cGMP Compliance Framework. Pharmaceutical USP mineral oil used in finished drug products is regulated under 21 CFR Part 210 + 211 (finished pharmaceuticals) and 21 CFR Parts 600-680 (biologics). Identity testing per 21 CFR 211.84(d)(2) requires at least one specific identity test on each container received; USP <201> UV absorbance + identification via specific-gravity + viscosity + IR spectrum + density are the standard pharmacopeial identity panel. ICH Q7 GMP for active pharmaceutical ingredients applies when mineral oil is used as API (oral laxative product); ICH Q3D + Q3C apply to elemental + residual-solvent impurities.

USP-NF 43 Compendial Specifications. Pharmacopeial mineral oil specifications (Light + Heavy): identification by specific gravity (light 0.83-0.86, heavy 0.86-0.89), viscosity at 40°C (light under 33.5 cSt, heavy 38.1 cSt or higher), refractive index, IR spectrum; UV absorbance per USP <201> not exceeding 0.10 absorbance unit at any wavelength 260-350 nm in DMSO extract (the critical polynuclear-aromatic test); readily carbonizable substances (test with concentrated sulfuric acid; mineral oil layer must remain colorless or near-colorless); solid paraffins (test with isopropyl alcohol cooling); neutrality (no titrable acidity or alkalinity); residue on ignition under 0.001%; heavy metals under 10 ppm; limit of polynuclear hydrocarbons per Ph. Eur. 2.2.45; ICH Q3D elemental impurities; ICH Q3C residual solvents.

DOT and Shipping. USP mineral oil is not regulated under 49 CFR DOT Hazardous Materials Regulations at any concentration. No UN number, no hazard class, no packing group. Shipped as standard non-hazardous combustible liquid in HDPE drums (5-30-55-gallon), HDPE 275-330-gallon IBC totes, and stainless or HDPE-lined tank trucks at bulk pharmaceutical-feedstock movements. Bulk-tanker delivery typically at 75-95°C if heavy grade is shipped warm to maintain flowable viscosity, or at ambient if light grade.

EPA Air Regulations. Mineral oil storage tanks not subject to 40 CFR Part 60 NSPS Subpart Kb (vapor pressure under 0.001 psi at room temperature, far below 0.75 psi threshold); not subject to Subpart K, KKK, or similar air regulations. Pharmaceutical manufacturing facilities subject to 40 CFR Part 63 Subpart GGG Pharmaceuticals Production NESHAP for organic HAP emissions; mineral oil is not a HAP and not a regulated air emission source.

FDA Direct + Indirect Food Contact Authorization. White mineral oil holds direct food-contact authorization per 21 CFR 172.878 (technical and pharmaceutical grades, with viscosity-specific use levels for specific food categories) and indirect food-contact authorization per 21 CFR 178.3620 (industrial release agents + lubricants meeting specified UV absorbance + viscosity requirements). USP-grade pharmaceutical mineral oil meets and substantially exceeds both food-contact specifications.

4. Storage System Specification

Bulk-Receipt and Raw-Material-Warehouse Storage. Pharmaceutical USP mineral oil arrives at the manufacturing facility raw-material warehouse via 5-gallon pails, 30-55-gallon HDPE drums, 275-330-gallon HDPE IBC totes, or stainless or HDPE-lined tank trucks (4500-6500 gallon delivery). Heavy-grade bulk-tanker deliveries at large pharmaceutical operations may be heated to 60-80°C in transit + at the receiving manifold to maintain flowable viscosity; light-grade deliveries are at ambient. Bulk-receipt storage tanks at large pharmaceutical operations are typically 304/316L stainless rather than HDPE because of the long-term hydrocarbon-swell concern with HDPE at extended-contact + heated mineral-oil service; HDPE rotomolded short-term staging tanks are appropriate at compounding pharmacies + small-batch operations + warehousing applications where working-stock turnover is under 6 months.

Tank Sizing and Heating. Typical bulk-receipt tank sizes: 1500-3000 gallons at compounding pharmacies + small-batch sterile-fill; 5000-15000 gallons at mid-size pharmaceutical manufacturing; 15000-40000 gallons at large-scale dermatologic + ophthalmic + OTC consumer-health manufacturing. Heavy-grade tanks include steam half-pipe coil or electric trace + insulation maintaining 40-60°C tank temperature for pumpable viscosity; light-grade is handled at ambient.

Compounding Pharmacy Working-Stock Storage. Compounding pharmacies + 503A + 503B operations stock USP mineral oil in 5-30 gallon HDPE drums + 1-5 gallon working-stock containers at the ingredient warehouse + sterile compounding anteroom + non-sterile compounding cleanroom. Drum + tote receiving uses HDPE-pump dispensing into smaller working stocks; working stocks at the compounding bench dispensed from FDA-grade HDPE bottles.

Product-Contact Formulation Tanks. Active formulation + compounding for finished topical / ophthalmic / oral / suppository preparations occurs in 316L electropolished sanitary stainless tanks per ASME BPE-2022 with internal surface finish Ra under 0.5 microns, all-welded 316L sanitary tri-clamp transfer piping, BPE diaphragm or ball valves, jacketed temperature control, top-mounted impeller agitation, CIP/SIP capability via spray-ball + steam-trap installation (cleaning agents include hot-water + saponifier blends like Alconox + sodium hydroxide solutions for hydrocarbon residue removal), and validated cleaning + steam-in-place cycles. These vessels are outside the HDPE network.

Secondary Containment. Bulk-receipt mineral-oil storage vessels at pharmaceutical operations are placed inside containment pans sized to 110% of largest single tank capacity per EPA SPCC 40 CFR Part 112 (mineral oil meets the EPA definition of oil under SPCC; SPCC compliance is mandatory for facilities with aggregate above-ground storage above 1320 gallons of oil including mineral oil, lubricating oil, and similar petroleum products). HDPE secondary containment pans + concrete trench drains + facility SPCC plan + monthly inspection + annual professional engineer certification of SPCC plan are standard at mineral-oil bulk-storage installations.

Atmospheric Vent and Bug Screen. Mineral oil's near-zero vapor pressure at room temperature eliminates VOC emissions from venting; atmospheric vents typically use a coarse bug-screen to prevent insect ingress + a hydrophobic dust filter to prevent particulate ingress. Sterilizing-grade vent filtration is not required at non-product-contact bulk-storage (vs. polyol pharma where vent sterility is more rigorously controlled).

5. Field Handling Reality

Operator PPE. Pharmaceutical operators handling USP mineral oil require standard pharmaceutical manufacturing PPE: cleanroom-grade gowning at sterile + cleanroom operations, safety glasses + lab coat + closed-toe shoes at non-cleanroom ingredient warehouse + bulk-receipt operations, nitrile gloves at all liquid-handling operations to prevent product cross-contamination + skin oil-exposure dermatitis (mineral oil is generally non-irritating but extended-contact dermal exposure can defat skin and trigger contact dermatitis in sensitive individuals). Spill-response gear at the bulk-receipt area. No respirator required at any handling temperature; no splash-shield required beyond standard safety glasses.

Microbial Bioburden Control. Mineral oil's water-immiscible nature and lack of nutrient content makes it inherently microbiostatic; bacterial + mold growth is rare in concentrated mineral oil (a_w effectively 0). Trace water + emulsion-formation in bulk storage can create localized conditions for microbial growth at the water-oil interface; bulk-storage best practice includes scheduled tank-bottom water drainage + visual inspection for water-phase accumulation + microbial monitoring per USP <1116>.

Spill Response. Mineral oil spill response is a petroleum-product cleanup: (1) deploy oil-only sorbent pads + booms (not water-based sorbents which do not absorb mineral oil), (2) collect into double-bagged poly waste for petroleum-waste profiling and disposal under facility-specific waste streams (typically non-RCRA, non-hazardous, profiled for recycling or incineration), (3) decontaminate spill area with degreaser + hot-water + detergent (mineral oil's water-immiscibility makes degreaser-based cleaning the appropriate decontamination route; oil residue requires multiple cleaning passes for full removal), (4) document spill volume + decontamination + containment integrity for the facility deviation + investigation system per 21 CFR 211.192 + EPA SPCC reporting for spills above reportable thresholds.

Slip Hazard. Mineral oil's extremely low coefficient of friction on hard floors creates a severe slip hazard at any bulk-receipt drum-handling + tote-handling + tank-fill operation. Slip-resistant floor mats + secondary containment + immediate floor cleaning protocols are essential at the bulk-receipt staging area; pharmaceutical safety programs include mineral-oil spill in the standard slip-trip-fall hazard inventory under OSHA 29 CFR 1910.22 General Walking-Working Surfaces. Mineral oil residue on smooth concrete or epoxy-coated floor surfaces creates persistent slip hazard requiring degreaser-based cleaning + traction-restoration.

Decontamination of Cross-Contamination Spills. Pharmaceutical manufacturing under 21 CFR 211.42 + 21 CFR 211.46 + 21 CFR 211.67 cleaning + cross-contamination prevention requires documented cleaning of any spill area + adjacent equipment + drains + transfer-piping returning to compendial-clean status. Mineral oil's water-immiscibility and persistence make spill-area decontamination more demanding than aqueous polyol spills; multi-pass degreaser cleaning + residual-test-swab verification is the standard cross-contamination clearance protocol.

Handling Temperature Awareness. Heavy-grade USP mineral oil at 60-80 cSt becomes increasingly viscous below 20°C and impractical to pump below 10°C; outdoor bulk-receipt + transfer in winter conditions in northern climates requires tank-jacket warming + transfer-line insulation + pump-suction-line trace heating. Light-grade USP mineral oil at 8-20 cSt remains pumpable down to 0-5°C without special heating measures.

Talk to OneSource Plastics

Listed price covers tank + standard fitting package; LTL freight is quoted separately to your delivery ZIP. Call 866-418-1777, use our freight estimator, or try our chemical tank recommender to narrow material selection.